2016-11-14T12:36:12-06:00 2015-12-31 910189318 Moss Adams LLP 975 Oak Street Suite 500 Eugene OR 97401 990 2015-02-27 473355381 Parker Institute for Cancer Immunotherapy PARK 6508047101 314 Lytton Ave Suite 200 Palo Alto CA 94301 Tom van loben sels Secretary 6508047101 2016-11-10 1 Wendy Campos P00448102 5416861040 2016-11-10 2015 2017-02-10 21:41:12Z X 314 Lytton Ave Suite 200 Palo Alto CA 94301 104061533 0 X www.parkerici.org X 2015 CA The Parker Institute for Cancer Immunotherapy (PICI) was created to encourage advances in cancer immunotherapy research and to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The Institute intends to achieve this goal by funding and establishing a consortium of preeminent academic and medical research institutions which will work collaboratively on research in the field of cancer immunology (the "Consortium"). 4 4 10 6 0 0 74021413 0 -518694 7045 73509764 64000000 0 1545875 0 0 3661244 69207119 4302645 5207689 578427 4629262 TO ENABLE REAL COLLABORATION, ACCELERATING THE MOST AMBITIOUS RESEARCH TO DELIVER NEW IMMUNOTHERAPIES ENGINEERED TO SAVE LIVES. 0 0 66989287 64000000 The Parker Institute for Cancer Immunotherapy encourages advances in cancer immunotherapy research and to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The Institute funds a consortium of preeminent academic and medical research institutions which work collaboratively on research in the field of cancer immunology. 66989287 1 1 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 1 10 0 1 10 1 0 0 0 0 0 0 0 0 0 0 X 4 4 1 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X Parker Institute for Cancer Immunotherapy 4159857311 1 Letterman Drive Suite D3500 San Francisco CA 94129 MICHAEL POLANSKY VICE PRESIDENT and DIRECTOR 1.00 X X 0 0 0 TOM VAN LOBEN SELS SECRETARY/Treasurer AND DIRECTOR 1.00 X X 0 0 0 Sean N Parker Chair of the Board and Director 1.00 X X 0 0 0 Laurie Glimcher Director 1.00 X 0 0 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 40.00 X 612424 0 51018 Adam M Kolom Vice President-Business Development 40.00 X 284849 0 2356 897273 0 53374 3 0 1 0 Arnold & Porter LLP 601 MASSACHUSETTS AVENUE NW WASHINGTON DC 20001 Legal Services 863441 The Boston Consulting Group Inc Two Embarcadero Center Suite 2400 San Francisco CA 94111 Professional Services 250000 Apercen Partners LLC 314 Lytton Ave Suite 200 Palo Alto CA 94301 Professional Services 240345 Linle J Froeb Events LLC 191 Stanyan Street San Francisco CA 941184240 Professional Services 131563 ANGELIQUE LOSCAR 2522 Chestnut Street San Francisco CA 94123 Consulting Services 114563 5 43473346 30548067 30548067 74021413 10489 10489 30022586 30551769 -529183 -529183 -529183 Settlement Proceeds 900099 7045 7045 7045 73509764 0 0 -511649 64000000 64000000 1207873 683646 524227 223996 85005 138991 6410 2433 3977 39088 14834 24254 68508 36892 31616 947056 489307 457749 261518 261518 993629 702045 291584 2333 2333 24300 9460 14840 77472 30161 47311 656674 255657 401017 401000 401000 124240 124240 733 733 5768 5768 Meals and Entertainment 156758 154607 2151 Pension Plan Fees 3999 3999 BANK CHARGES 3800 3800 Payroll Processing Fees 1704 1704 260 260 69207119 66989287 2217832 0 0 592138 0 1635874 0 1323346 0 9932 0 1010989 309526 733 0 308793 0 326617 0 5207689 0 578427 0 578427 X 0 2979299 0 1649963 0 4629262 0 5207689 4302645 326617 0 X 0 1 X 1 0 X 74021413 74021413 74021413 74021413 71059855 2961558 10489 10489 7045 7045 74038947 X Part II, Short Year Explanation: This is the initial year of the organization. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 244777 244777 32664 733 31931 32085 32085 308793 LEASE GUARANTEE 326617 326617 74487053 977289 977289 73509764 0 73509764 69857791 650672 650672 69207119 0 69207119 1 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE BOX 69 NEW YORK NY 10065 912154267 501(c)(3) 16000000 Support research in field of cancer immunotherapy University of California San Francisco 333 CALIFORNIA ST 315 SAN FRANCISCO CA 94143 946036493 State of CALIFORNIA 16000000 Support research in field of cancer immunotherapy Trustees of the UNIVERSITY OF PENNSYLVANIA 3160 CHESTNUT STREET SUITE 200 PHILADELPHIA PA 19104 231352685 501(c)(3) 16000000 Support research in field of cancer immunotherapy UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1400 PRESSLER STREET FCT205223 HOUSTON TX 77030 746001118 state of Texas 16000000 Support research in field of cancer immunotherapy 4 Part I Line 2 The organization awards grants subject to a Master Collaboration Agreement and a specific grant agreement applicable to each institution. X 1 1 X X X 0 0 0 0 0 0 0 0 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 487424 0 125000 0 0 0 0 0 51018 0 663442 0 0 0 Adam M Kolom Vice President-Business Development 84849 0 200000 0 0 0 0 0 2356 0 287205 0 0 0 Part I, Line 3 THE BOARD OF DIRECTORS REVIEWS ANY PROPOSED COMPENSATION TO ENSURE THAT, IN EACH CASE, IT IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATED ORGANIZATIONS. Tom Van Loben Sels Officer/Director 240345 Professional Services 0 Sean N Parker Foundation Common control 330000 LEASE GUARANTEE 0 X 1 30548067 FMV 0 0 0 Form 990, Part VI, Section A, line 2 Tom van Loben Sels and Sean Parker have a business relationship. Tom van Loben Sels and Michael Polansky have a business relationship. Michael Polansky is an employee of an entity owned by Sean Parker. Form 990, Part VI, Section A, line 4 The bylaws were amended to establish a Board of Trustees. Form 990, Part VI, Section B, line 11 The audit committee reviews the Form 990. The Form is distributed to the Board prior to filing. Form 990, Part VI, Section B, line 12c The Board authorizes and oversees an annual review of the admnistration of the conflict of interest policy. The review considers the level of compliance with the policy, the continuing suitability of the policy, and whether the policy should be modified and improved. Form 990, Part VI, Section B, line 15 The Board of Directors will review any proposed compensation to ensure that, in each case, it is fair and reasonable based on comparability data showing compensation paid for comparable services at similarly situated organizations. Form 990, Part VI, Section C, line 19 Financial statements are made available to the public upon request. Sean N Parker Foundation 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 274389819 SUPPORTS NONPROFIT ORGANIZATIONS CA 501(C)(3) PF N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SEAN N PARKER FOUNDATION C 43473346 FMV